A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis
- 1 September 2016
- journal article
- Published by Elsevier BV in Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale
- Vol. 150 (3), 506-515
- https://doi.org/10.1016/j.chest.2016.02.641
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- How I treat heparin-induced thrombocytopeniaBlood, 2012
- Heparin-Induced Thrombocytopenia: An UpdateSeminars in Thrombosis and Hemostasis, 2012
- PF4/Heparin Antibody Testing and Treatment of Heparin-Induced Thrombocytopenia in the Intensive Care UnitClinical and Applied Thrombosis/hemostasis, 2012
- HITlights: A career perspective on heparin‐induced thrombocytopeniaAmerican Journal of Hematology, 2012
- The Direct Medical Costs Associated with Suspected Heparin-Induced ThrombocytopeniaPharmacoEconomics, 2011
- What is the potential for overdiagnosis of heparin‐induced thrombocytopenia?American Journal of Hematology, 2007
- Receiver-Operating Characteristic Analysis for Evaluating Diagnostic Tests and Predictive ModelsCirculation, 2007
- Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin‐induced thrombocytopenia in two clinical settingsJournal of Thrombosis and Haemostasis, 2006
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinThe New England Journal of Medicine, 1995
- Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.JCI Insight, 1994